FDA | International Myeloma Foundation

ODAC vote

Week in Review

June 5

A Closer Look at the FDA ODAC Vote Recommending DARZALEX FASPRO® as Treatment for High-Risk Smoldering Myeloma

What does the FDA approval of MRD testing for myeloma mean for patients and drug development?

June 20

What does the FDA approval of MRD testing for myeloma mean for patients and drug development?

close-up of CAR T-cells

Week in Review

March 21

FDA ODAC Recommends Early Use of Cilta-cel and Ide-cel as Treatments for Relapsed/Refractory Multiple Myeloma

elderly Asian woman getting vaccinated

Week in Review

March 7

Whatever Happened to COVID-19?

hand holding phone with ChatGPT

Week in Review

June 1

Getting the Most Out of Chatbots: The Promise and Perils of Artificial Intelligence

add blog fda envelope original

Week in Review

July 16

Good News: FDA Panel Votes to Approve Belantamab Mafodotin

IV infusion

Week in Review

March 21

In the News: New Drug Updates and Notes on the Environment

Researcher looks at a slide sample next to a microscope.

Week in Review

December 27

FDA Approvals and Prize-Winning Research Are Welcome Good News for Myeloma Patients

FDA stamp of approval

Week in Review

November 8

FDA Weighs in On Immune Therapies

Subscribe to FDA

Give Where Most Needed